[The place of targeted treatments: receptor tyrosine kinase inhibitors].
Bréchot, J-M
[The place of targeted treatments: receptor tyrosine kinase inhibitors]. [electronic resource] - Revue de pneumologie clinique Nov 2004 - 3S68-71 p. digital
Publication Type: English Abstract; Journal Article; Review
0761-8417
Humans
Lung Neoplasms--drug therapy
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Receptor, ErbB-2--antagonists & inhibitors
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
[The place of targeted treatments: receptor tyrosine kinase inhibitors]. [electronic resource] - Revue de pneumologie clinique Nov 2004 - 3S68-71 p. digital
Publication Type: English Abstract; Journal Article; Review
0761-8417
Humans
Lung Neoplasms--drug therapy
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Receptor, ErbB-2--antagonists & inhibitors
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors